Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Dec;83(12):1722–1729. doi: 10.1054/bjoc.2000.1497

HERG potassium channels are more frequently expressed in human endometrial cancer as compared to non-cancerous endometrium

A Cherubini 1, G L Taddei 2, O Crociani 1, M Paglierani 2, A M Buccoliero 2, L Fontana 1, I Noci 3, P Borri 3, E Borrani 3, M Giachi 3, A Becchetti 4, B Rosati 4, E Wanke 4, M Olivotto 1, A Arcangeli 1
PMCID: PMC2363441  PMID: 11104572

Abstract

HERG K+channels, besides contributing to regulate cardiac and neuronal excitability, are preferentially expressed in tumour cell lines of different histogenesis, where their role in the development and maintenance of the neoplastic phenotype is under study. We show here that both herg gene and HERG protein are expressed with high frequency in primary human endometrial cancers, as compared to normal and hyperplastic endometrium. RT-PCR and immunohistochemistry, using specific anti-HERG antibodies developed in our laboratory, were applied to tissue specimens obtained from 18 endometrial cancers and 11 non-cancerous endometrial tissues. herg RNA and HERG protein are expressed in 67% and 82%, respectively, of cancerous, while in only 18% of non-cancerous tissues. In particular, no expression was found in endometrial hyperplasia. Moreover, electrophysiological experiments confirmed the presence of functioning HERG channels on the plasma membrane of tumour cells. On the whole, these data are the first demonstration of the presence of HERG channels in primary human neoplasias, and could candidate HERG as a potential tool capable of marking cancerous versus hyperplastic endometrial growth. © 2000 Cancer Research Campaign http://www.bjcancer.com

Keywords:  HERG; endometrial cancer; endometrial hyperplasia; tumour markers, K+channels

Full Text

The Full Text of this article is available as a PDF (305.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arcangeli A., Becchetti A., Mannini A., Mugnai G., De Filippi P., Tarone G., Del Bene M. R., Barletta E., Wanke E., Olivotto M. Integrin-mediated neurite outgrowth in neuroblastoma cells depends on the activation of potassium channels. J Cell Biol. 1993 Sep;122(5):1131–1143. doi: 10.1083/jcb.122.5.1131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arcangeli A., Bianchi L., Becchetti A., Faravelli L., Coronnello M., Mini E., Olivotto M., Wanke E. A novel inward-rectifying K+ current with a cell-cycle dependence governs the resting potential of mammalian neuroblastoma cells. J Physiol. 1995 Dec 1;489(Pt 2):455–471. doi: 10.1113/jphysiol.1995.sp021065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Arcangeli A., Rosati B., Cherubini A., Crociani O., Fontana L., Passani B., Wanke E., Olivotto M. Long-term exposure to retinoic acid induces the expression of IRK1 channels in HERG channel-endowed neuroblastoma cells. Biochem Biophys Res Commun. 1998 Mar 27;244(3):706–711. doi: 10.1006/bbrc.1998.8319. [DOI] [PubMed] [Google Scholar]
  4. Arcangeli A., Rosati B., Cherubini A., Crociani O., Fontana L., Ziller C., Wanke E., Olivotto M. HERG- and IRK-like inward rectifier currents are sequentially expressed during neuronal development of neural crest cells and their derivatives. Eur J Neurosci. 1997 Dec;9(12):2596–2604. doi: 10.1111/j.1460-9568.1997.tb01689.x. [DOI] [PubMed] [Google Scholar]
  5. Arcangeli A., Rosati B., Crociani O., Cherubini A., Fontana L., Passani B., Wanke E., Olivotto M. Modulation of HERG current and herg gene expression during retinoic acid treatment of human neuroblastoma cells: potentiating effects of BDNF. J Neurobiol. 1999 Aug;40(2):214–225. [PubMed] [Google Scholar]
  6. Babij P., Askew G. R., Nieuwenhuijsen B., Su C. M., Bridal T. R., Jow B., Argentieri T. M., Kulik J., DeGennaro L. J., Spinelli W. Inhibition of cardiac delayed rectifier K+ current by overexpression of the long-QT syndrome HERG G628S mutation in transgenic mice. Circ Res. 1998 Sep 21;83(6):668–678. doi: 10.1161/01.res.83.6.668. [DOI] [PubMed] [Google Scholar]
  7. Bianchi L., Wible B., Arcangeli A., Taglialatela M., Morra F., Castaldo P., Crociani O., Rosati B., Faravelli L., Olivotto M. herg encodes a K+ current highly conserved in tumors of different histogenesis: a selective advantage for cancer cells? Cancer Res. 1998 Feb 15;58(4):815–822. [PubMed] [Google Scholar]
  8. Binggeli R., Weinstein R. C. Membrane potentials and sodium channels: hypotheses for growth regulation and cancer formation based on changes in sodium channels and gap junctions. J Theor Biol. 1986 Dec 21;123(4):377–401. doi: 10.1016/s0022-5193(86)80209-0. [DOI] [PubMed] [Google Scholar]
  9. Burks R. T., Kessis T. D., Cho K. R., Hedrick L. Microsatellite instability in endometrial carcinoma. Oncogene. 1994 Apr;9(4):1163–1166. [PubMed] [Google Scholar]
  10. Burton J. L., Wells M. Recent advances in the histopathology and molecular pathology of carcinoma of the endometrium. Histopathology. 1998 Oct;33(4):297–303. doi: 10.1046/j.1365-2559.1998.00560.x. [DOI] [PubMed] [Google Scholar]
  11. Chatzaki E., Gallagher C. J., Iles R. K., Ind T. E., Nouri A. M., Bax C. M., Grudzinskas J. G. Characterisation of the differential expression of marker antigens by normal and malignant endometrial epithelium. Br J Cancer. 1994 Jun;69(6):1010–1014. doi: 10.1038/bjc.1994.198. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chiesa N., Rosati B., Arcangeli A., Olivotto M., Wanke E. A novel role for HERG K+ channels: spike-frequency adaptation. J Physiol. 1997 Jun 1;501(Pt 2):313–318. doi: 10.1111/j.1469-7793.1997.313bn.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Creasman W. T. Prognostic significance of hormone receptors in endometrial cancer. Cancer. 1993 Feb 15;71(4 Suppl):1467–1470. doi: 10.1002/cncr.2820710411. [DOI] [PubMed] [Google Scholar]
  14. Faravelli L., Arcangeli A., Olivotto M., Wanke E. A HERG-like K+ channel in rat F-11 DRG cell line: pharmacological identification and biophysical characterization. J Physiol. 1996 Oct 1;496(Pt 1):13–23. doi: 10.1113/jphysiol.1996.sp021661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hamill O. P., Marty A., Neher E., Sakmann B., Sigworth F. J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981 Aug;391(2):85–100. doi: 10.1007/BF00656997. [DOI] [PubMed] [Google Scholar]
  16. Kohler M. F., Nishii H., Humphrey P. A., Saski H., Marks J., Bast R. C., Clarke-Pearson D. L., Boyd J., Berchuck A. Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasias. Am J Obstet Gynecol. 1993 Sep;169(3):690–694. doi: 10.1016/0002-9378(93)90644-x. [DOI] [PubMed] [Google Scholar]
  17. Li X., Xu J., Li M. The human delta1261 mutation of the HERG potassium channel results in a truncated protein that contains a subunit interaction domain and decreases the channel expression. J Biol Chem. 1997 Jan 10;272(2):705–708. doi: 10.1074/jbc.272.2.705. [DOI] [PubMed] [Google Scholar]
  18. Olivotto M., Arcangeli A., Carlà M., Wanke E. Electric fields at the plasma membrane level: a neglected element in the mechanisms of cell signalling. Bioessays. 1996 Jun;18(6):495–504. doi: 10.1002/bies.950180612. [DOI] [PubMed] [Google Scholar]
  19. Pardo L. A., del Camino D., Sánchez A., Alves F., Brüggemann A., Beckh S., Stühmer W. Oncogenic potential of EAG K(+) channels. EMBO J. 1999 Oct 15;18(20):5540–5547. doi: 10.1093/emboj/18.20.5540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Petrecca K., Atanasiu R., Akhavan A., Shrier A. N-linked glycosylation sites determine HERG channel surface membrane expression. J Physiol. 1999 Feb 15;515(Pt 1):41–48. doi: 10.1111/j.1469-7793.1999.041ad.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pond A. L., Scheve B. K., Benedict A. T., Petrecca K., Van Wagoner D. R., Shrier A., Nerbonne J. M. Expression of distinct ERG proteins in rat, mouse, and human heart. Relation to functional I(Kr) channels. J Biol Chem. 2000 Feb 25;275(8):5997–6006. doi: 10.1074/jbc.275.8.5997. [DOI] [PubMed] [Google Scholar]
  22. Porter P. L., Gown A. M., Kramp S. G., Coltrera M. D. Widespread p53 overexpression in human malignant tumors. An immunohistochemical study using methacarn-fixed, embedded tissue. Am J Pathol. 1992 Jan;140(1):145–153. [PMC free article] [PubMed] [Google Scholar]
  23. Risinger J. I., Berchuck A., Kohler M. F., Watson P., Lynch H. T., Boyd J. Genetic instability of microsatellites in endometrial carcinoma. Cancer Res. 1993 Nov 1;53(21):5100–5103. [PubMed] [Google Scholar]
  24. Sanguinetti M. C., Jiang C., Curran M. E., Keating M. T. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell. 1995 Apr 21;81(2):299–307. doi: 10.1016/0092-8674(95)90340-2. [DOI] [PubMed] [Google Scholar]
  25. Taskin M., Lallas T. A., Barber H. R., Shevchuk M. M. bcl-2 and p53 in endometrial adenocarcinoma. Mod Pathol. 1997 Jul;10(7):728–734. [PubMed] [Google Scholar]
  26. Taylor-Papadimitriou J., Epenetos A. A. Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy. Trends Biotechnol. 1994 Jun;12(6):227–233. doi: 10.1016/0167-7799(94)90121-X. [DOI] [PubMed] [Google Scholar]
  27. Warmke J. W., Ganetzky B. A family of potassium channel genes related to eag in Drosophila and mammals. Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3438–3442. doi: 10.1073/pnas.91.8.3438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Zhou Z., Gong Q., Epstein M. L., January C. T. HERG channel dysfunction in human long QT syndrome. Intracellular transport and functional defects. J Biol Chem. 1998 Aug 14;273(33):21061–21066. doi: 10.1074/jbc.273.33.21061. [DOI] [PubMed] [Google Scholar]
  29. Zhou Z., Gong Q., Epstein M. L., January C. T. HERG channel dysfunction in human long QT syndrome. Intracellular transport and functional defects. J Biol Chem. 1998 Aug 14;273(33):21061–21066. doi: 10.1074/jbc.273.33.21061. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES